High Wycombe, Buckinghamshire. (PRWEB UK) 30 July 2016
Sky Medical Technology is a highly innovative UK based medical devices company that has developed a ground-breaking neuromuscular electrostimulation technology platform, On-Pulse®. Embedded in the geko™ device, the OnPulse™ technology has been tailored to the needs of different medical application areas selling both direct and through strategic global partnerships or distributors in each major clinical area. Clinical areas of focus and growth include DVT prevention, prevention and reduction of oedema, wound healing, and continence. The goal in each clinical area is to improve clinical outcomes and patient care whilst saving health system resources. Firstkind also markets the technology, branded firefly™, to elite sport athletes to relieve muscle soreness after high exertion, and to reduce swelling after injury.
Sky Medical Technology is one of 15 shortlisted from a long list of top performing SMEs, and is recognised alongside CaféPod, Carwow, Darwin & Wallace, Eve Sleep, Flyvictor, Go Outdoors, Gousto, Housekeep, MyShowcase, Notonthehighstreet.com, Outplay Entertainment, Oxford Space Systems, PrivateFly, Scoota. Each shortlisted company will be profiled in coming weeks before eight finalists are selected on the 8th August for the final judging stage. The winner of this award, sponsored by Smith & Williamson, will be determined by a dedicated judging panel in combination with a public vote. A public voting campaign will be based on video interviews with senior representatives of each finalist company.
All winners will be revealed at the Growth Investor Awards black tie dinner held on 3rd November at the Marriott Grosvenor Square, Mayfair, London.
Bernard Ross, CEO said: ‘We are delighted to be shortlisted for this award. Growth investment has materially changed the value of our company. It has enabled us to prove that OnPulse™ is a genuine platform technology, generating revenues in new therapy areas internationally, including North America, providing economic and clinical benefits to more patients than previously considered and access to new patients where current spend is greater a £50bn a year. Taking the technology from an idea to a product that saves lives has been hugely rewarding and our investors share this vision. They rightly also look for a healthy return on their investment. Through growth investment we now have clinical data and sales in diabetic and venous wound care, DVT prevention, enhanced post-surgical recovery (getting people out of hospital quicker) for a wide range of patient groups including frail and elderly patients recovering from debilitating foot surgery. It is also a pleasure to see product conceived, developed and manufactured in the UK being sold in many markets of the world including China.
The awards programme is guided by an Advisory Board including angel investor and entrepreneur Sherry Coutu CBE, Co-founder of the Scale Up Institute; Luke Johnson, Chairman of Risk Capital Partners; Claire Cockerton, Founder and Ambassador of Innovate Finance; Tim Hames, Director General of the British Private Equity and Venture Capital Association (BVCA); Emma Jones MBE, CEO of Enterprise Nation; Simon Devonshire OBE, Entrepreneur in Residence at BIS; and Michael Hayman MBE, Co-founder of Seven Hills.
Commenting on the new Growth Champion of the Year award, which recognises scale up businesses that have best optimised growth capital, Simon Devonshire OBE said, "Britain has more engaged investors and a more active eco-system than anywhere else in Europe and Growth Champions bring this story to life. It’s important to show how growth capital is being used to scale and transform the country’s economic landscape.”
The Awards are organised by Intelligent Partnership (IP), the UK’s leading provider of research and education in alternative investments, and supported by partners including the BVCA, EISA, UKCFA, Centre for Entrepreneurs, The Entrepreneur Network and The Supper Club.
Guy Tolhurst, Managing Director of Intelligent Partnership, which organises the Growth Investor Awards, commented: “The finalists of our new Growth Champion of the Year award are among the UK’s best performing scale up SMEs - and their story of growth capital at work really brings the Growth Investor Awards campaign to life.”
The 2016 campaign for the Growth Investor Awards is supported by a family of sponsors including Smith & Williamson, Bovill, Bates Wells Braithwaite, LGBR Capital, Mainspring, RAM Capital Partners, MICAP, and RW Blears.
Winners will be revealed at the Growth Investor Awards black tie dinner held on the evening of Thursday 3rd November at the Marriott Grosvenor Square in Mayfair, London. Visit growthinvestorawards.com/shortlist for a full list of all finalists and information on how to attend the event.